• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌、子宫内膜癌和卵巢癌的流行病学及一级预防。简要概述。

Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.

作者信息

Kelsey J L, Whittemore A S

机构信息

Department of Health Research and Policy, Stanford University School of Medicine, CA 94305-5092.

出版信息

Ann Epidemiol. 1994 Mar;4(2):89-95. doi: 10.1016/1047-2797(94)90052-3.

DOI:10.1016/1047-2797(94)90052-3
PMID:8205289
Abstract

Cancers of the breast, endometrium, and ovary account for 41% of incident cancers among women. Many risk factors for breast cancer have been identified, but most are associated with only modest elevations in risk. Also, of all the risk factors identified, few are likely to be affected by intervention programs. The pathogenesis of breast cancer is not well understood, but estrogen and possibly estrogen plus progesterone are likely to be etiologically involved. For endometrial cancer, a major etiologic pathway is exposure to estrogen without cyclic exposure to progesterone. Most of the established risk factors for endometrial cancer appear to affect risk at least in part through this pathway. Only a few risk factors for ovarian cancer have been identified. The two most commonly suggested etiologic mechanisms for ovarian cancer are (a) that suppression of ovulation reduces risk and (b) that suppression of pituitary gonadotropins reduces risk. Each hypothesis is consistent with some, but not all, of the data. Prospects for the primary prevention of these cancers are discouraging at present because few of the risk factors identified to date are readily subject to modification, especially for breast cancer, and the underlying etiologies of these cancers are not well understood, particularly for breast and ovarian cancers.

摘要

乳腺癌、子宫内膜癌和卵巢癌占女性新发癌症的41%。已确定了许多乳腺癌的风险因素,但大多数仅与风险适度升高相关。此外,在所有已确定的风险因素中,很少有因素可能会受到干预项目的影响。乳腺癌的发病机制尚未完全明确,但雌激素以及可能的雌激素加孕激素可能在病因上与之相关。对于子宫内膜癌,一个主要的病因途径是暴露于雌激素而没有周期性地暴露于孕激素。大多数已确定的子宫内膜癌风险因素似乎至少部分通过这一途径影响风险。仅确定了少数卵巢癌的风险因素。卵巢癌最常被提及的两种病因机制是:(a)抑制排卵可降低风险;(b)抑制垂体促性腺激素可降低风险。每种假说都与部分而非全部数据相符。目前,这些癌症一级预防的前景不容乐观,因为迄今为止确定的风险因素中很少有能轻易改变的,尤其是乳腺癌,而且这些癌症的潜在病因尚未完全明确,特别是乳腺癌和卵巢癌。

相似文献

1
Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.乳腺癌、子宫内膜癌和卵巢癌的流行病学及一级预防。简要概述。
Ann Epidemiol. 1994 Mar;4(2):89-95. doi: 10.1016/1047-2797(94)90052-3.
2
The prevention of breast cancer through reduced ovarian steroid exposure.通过减少卵巢甾体激素暴露预防乳腺癌。
Acta Oncol. 1992;31(2):167-74. doi: 10.3109/02841869209088898.
3
Prevention of cancers of the breast, endometrium and ovary.预防乳腺癌、子宫内膜癌和卵巢癌。
Oncogene. 2004 Aug 23;23(38):6379-91. doi: 10.1038/sj.onc.1207899.
4
Dietary factors and cancers of breast, endometrium, and ovary: strategies for modifying fat intake in African American women.饮食因素与乳腺癌、子宫内膜癌和卵巢癌:非裔美国女性改变脂肪摄入的策略。
Am J Obstet Gynecol. 1997 Jun;176(6):S255-64. doi: 10.1016/s0002-9378(97)70384-3.
5
Cancer risk and PCOS.癌症风险与多囊卵巢综合征。
Steroids. 2013 Aug;78(8):782-5. doi: 10.1016/j.steroids.2013.04.004. Epub 2013 Apr 24.
6
Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings.雌激素与乳腺癌、子宫内膜癌和卵巢癌的病因——来自流行病学研究结果的证据与假说
J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):357-64. doi: 10.1016/s0960-0760(00)00113-8.
7
Sex steroids and breast cancer prevention.性类固醇与乳腺癌预防。
J Natl Cancer Inst Monogr. 1994(16):139-47.
8
Update on cancer control in women.女性癌症防治的最新情况。
Int J Gynaecol Obstet. 2000 Aug;70(2):263-303. doi: 10.1016/s0020-7292(00)00298-8.
9
Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative.女性健康倡议中膳食镉暴露与乳腺癌、子宫内膜癌和卵巢癌风险
Environ Health Perspect. 2014 Jun;122(6):594-600. doi: 10.1289/ehp.1307054. Epub 2014 Mar 14.
10
Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.50 岁及以上白人女性的乳腺癌、子宫内膜癌和卵巢癌风险预测:来自基于人群的队列研究的推导和验证。
PLoS Med. 2013;10(7):e1001492. doi: 10.1371/journal.pmed.1001492. Epub 2013 Jul 30.

引用本文的文献

1
Identification of sequence polymorphisms in the mitochondrial displacement loop as risk factors for sporadic and familial breast cancer.将线粒体置换环中的序列多态性鉴定为散发性和家族性乳腺癌的风险因素。
Tumour Biol. 2014 May;35(5):4773-7. doi: 10.1007/s13277-014-1626-5. Epub 2014 Jan 16.
2
Salpingectomy to prevent ovarian cancer: A Countercurrents Series.输卵管切除术预防卵巢癌:逆流系列
Curr Oncol. 2013 Jun;20(3):145-7. doi: 10.3747/co.20.1471.
3
Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort.
瑞典全国队列研究中生育间隔与侵袭性上皮性卵巢癌的母亲风险
Cancer Causes Control. 2008 Dec;19(10):1131-7. doi: 10.1007/s10552-008-9178-x. Epub 2008 May 29.
4
A population-based cohort study of HRT use and breast cancer in southern Sweden.瑞典南部基于人群的激素替代疗法使用与乳腺癌队列研究。
Br J Cancer. 2001 Sep 1;85(5):674-7. doi: 10.1054/bjoc.2001.1899.
5
Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.人类轻度内源性激素变化的显著影响:低剂量测试的考量
Environ Health Perspect. 2001 Mar;109 Suppl 1(Suppl 1):21-6. doi: 10.1289/ehp.01109s121.
6
Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer.托瑞米芬。对其治疗晚期乳腺癌的药理特性及临床疗效的综述。
Drugs. 1997 Jul;54(1):141-60. doi: 10.2165/00003495-199754010-00014.
7
Intake of dairy products and the risk of breast cancer.乳制品摄入与乳腺癌风险
Br J Cancer. 1996 Mar;73(5):687-91. doi: 10.1038/bjc.1996.119.